Table 4

Guideline-directed medical therapy (GDMT) at the time of discharge in patients undergoing coronary angiography (CAG) with heart failure with reduced ejection fraction (HFrEF)

ParametersOverallOCAD
n=119 (45.8%)
NOCAD
n=141 (54.2%)
OR (95% CI)P value
Antiplatelet medications213 (81.9)114 (95.8)99 (70.2)9.6 (3.7 to 25.1)<0.0001
ACE-I or ARBs205 (78.8)93 (71.2)112 (79.4)0.92 (0.51 to 1.7)NS*
Beta-blockers231 (88.8)104 (87.4)137 (90.1)0.76 (0.35 to 1.6)NS*
Aldosterone blocking agents117 (45.0)49 (41.2)58 (48.2)0.75 (0.45 to 1.2)NS*
Diuretics140 (53.8)55 (46.2)85 (60.3)0.56 (0.34 to 0.92)0.02
  • *P>0.10.

  • ACE-I, ACE inhibitor; ARB, angiotensin receptor blocker; NOCAD, non-obstructive coronary artery disease; NS, not significant; OCAD, obstructive coronary artery disease.